Latest 5-Androstenediol Stories

2008-08-07 09:00:14

Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), the world leader in the development of a new class of small molecule compounds based on endogenous steroid hormones, today reported on the Company's progress in its drug development programs in the areas of metabolic disorders, inflammatory conditions and cancer, and announced financial results for the second quarter of 2008. Recent Progress in Drug Development Programs During the second quarter of 2008, Hollis-Eden continued to...

2005-07-15 15:36:48

By Maggie Fox WASHINGTON (Reuters) - Companies seeking government contracts under the new Bioshield law designed to create a biosecurity industry complained on Thursday that bureaucracy was slowing them down. They said federal officials were moving too slowly to create stockpiles of drugs, vaccines and other products that might protect Americans against a biological, chemical, nuclear or radioactive attack. The Project BioShield Act of 2004 was passed last year to provide $5.6 billion...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.